Insular Thyroid Carcinoma: Collective Analysis of Clinicohistologic Prognostic Factors and Treatment Effect with Radioiodine or Radiation Therapy

Journal of the American College of Surgeons

Volumn 203, Issue 5, 2006, Pages 715-722

  Lai, Hung Wen ^a   Lee, Chen Hsen ^a   Chen, Jui Yu ^a   Tseng, Ling Ming ^a   Yang, An Hang ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE THERAPY; SCHOOL CHILD; THYROID CARCINOMA;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TAIWAN; THYROID NEOPLASMS;

EID: 33751053831     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2006.07.008     Document Type: Article

References (30)

1. Carcangiu M.L., Zampi G., and Rosai J. Poorly differentiated (insular) thyroid carcinoma: a reinterpretation of Langhans wuchernde struma. Am J Surg Pathol 8 (1984) 655-668
2. Langhans T. Uber die epithelialen Formen der malignan Struma. Virchows Arch Pathol Anat 189 (1907) 69-188
3. Sasaki A., Daa T., Kashima K., et al. Insular component as a risk factor of thyroid carcinoma. Pathol. Int 46 (1996) 939-946
4. Pilotti S., Collini P., Mariani L., et al. Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 21 (1997) 1466-1473
5. Van den Brekel M.W.M., Hekkenberg R.J., Asa S.L., et al. Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope 107 (1997) 254-259
6. Rodriguez L.M., Parrilla P., Moreno A., et al. Insular carcinoma: an infrequent subtype of thyroid cancer. J Am Coll Surg 187 (1998) 503-508
7. Lam K.-Y., Lo C.-Y., Chan K.-W., and Wan K.-Y. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institute and a review of the significance of p53 and p21. Ann Surg 231 (2000) 329-338
8. Pellegriti G., Giuffrida D., Scollo C., et al. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis. Cancer 95 (2002) 2076-2085
9. World Health Organization classification of tumours. In: DeLellis R.A., Lloyd R.V., Heitz P.U., and Eng C. (Eds). Pathology and genetics of tumours of endocrine organs (2004), IARC Press, Lyon, France
10. Flynn S.D., Formann B.H., Stewart A.F., and Kinder B.K. Poorly differentiated (insular) carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms. Surgery 104 (1988) 963-970
11. Killeen R.M., Barnes L., Watson C.G., et al. Poorly differentiated (insular) thyroid carcinoma. Arch Otolaryngol Head Neck Surg 116 (1990) 1082-1086
12. Justin E.P., Seabold J.E., Robinson R.A., et al. Insular carcinoma: a distinct thyroid carcinoma with associated iodine-131 localization. J Nucl Med 32 (1991) 1358-1363
13. Bal C., Padhy A.K., Panda S., et al. "Insular" carcinoma of thyroid: a subset of anaplastic thyroid malignancy with a less aggressive clinical course. Clin Nucl Med 18 (1993) 1056-1058
14. Papotti M., Micca F.B., Favero A., et al. Poorly differentiated thyroid carcinomas with primordial cell component: a group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 17 (1993) 291-301
15. Ashfaq R., Vuitch F., Delgado R., and Albores-Saavedra J. Papillary and follicular thyroid carcinomas with an insular component. Cancer 73 (1994) 416-423
16. Albores-Saavedra J., Housini I., Vuitch F., and Synder III W.H. Macrofollicular variant of papillary thyroid carcinoma with minor insular component. Cancer 80 (1997) 1110-1116
17. Asakawa H., Kobayashi T., Komoike Y., et al. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma. Anticancer Res 17 (1997) 2757-2762
18. Bose S.M., Ravindra N., Girdhar G., and Bhattacharya A. Clavicular metastasis of insular carcinoma of the thyroid showing increased uptake in the presence of a functioning thyroid gland. Clin Nucl Med 23 (1998) 774-775
19. Albareda M., Puig-Domingo M., Wengrowicz S., et al. Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid 8 (1998) 385-391
20. Machens A., Hinze R., Lautenschlager C., and Dralle H. Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. Arch Surg 136 (2001) 941-944
21. Rijhwani A., and Satish G.N. Insular carcinoma of the thyroid in a 10-year-old child. J Pediatr Surg 38 (2003) 1083-1085
22. Volante M., Landolfi S., Chiusa L., et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100 (2004) 950-957
23. Leong J.-L., Yuen H.W., LiVolsi V.A., et al. Insular carcinoma of the thyroid with jugular vein invasion. Head Neck (2004) 642-646
24. Luna-Ortiz K., Hurtadol-Lopez L.M., Dominguez-Malagon H., et al. Clinical course of insular thyroid carcinoma. Med Sci Monit 10 (2004) 108-111
25. Chao T.-C., Lin J.-D., and Chen M.-F. Insular carcinoma. infrequent subtype of thyroid cancer with aggressive clinical course. World J Surg 28 (2004) 393-396
26. Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer 12 (2005) 245-262
27. Xing M., Westra W.H., Tufano R.P., et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90 (2005) 6373-6379
28. Soares P., Trovisco V.S., Rocha A.S., et al. BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinoma. Virchows Arch 444 (2004) 572-576
29. Nikiforovak M.N., Kimura E.T., Gandhi M., et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinoma. J Clin Endocrinol Metab 88 (2003) 5399-5404
30. Salvatore G., Falco V.D., Salerno P., et al. BRAF is a therapeutic target in aggressive thyroid carcinoma. Clin Cancer Res 12 (2006) 1623-1629